CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE

CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE

The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAUL ALLEN SUTTON, PIOTR KARPINSKI, ELIAS NDZIE, DIMITRIS PAPOUTSAKIS, STEPHANIE MONNIER
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quina zolin-4-il]-pirrol-2,5-diona, la cual se puede utilizar, por ejemplo, para trasplante.